The expert in urologic oncology spoke about new innovations that he believes will aid in treating patients with urologic cancers.
Adam J. Gadzinski, MD, MS
Advertisement
Articles by Adam J. Gadzinski, MD, MS
An expert in urologic oncology seeks to answer further questions regarding the use of telemedicine for this patient population.
Study results revealed the impact of a rurally focused telemedicine program on patient outcomes.
The study was designed to determine the impact of a rurally focused telemedicine program on patient outcomes.
The study assessed the impact of a rurally focused telemedicine program on patient outcomes in the urologic oncology outpatient clinic at the University of Washington Medical Center.
The study sought to determine the impact of a rurally focused telemedicine program on patient outcomes.
Gadzinski spoke about the most exciting aspect of the research coming out of the 21st Annual Meeting of the Society of Urologic Oncology (SUO).
Advertisement
Latest Updated Articles
Adam J. Gadzinski, MD, MS, on the Limitations of a Study Assessing the Impact of Telemedicine on Patient-Reported OutcomesPublished: December 28th 2020 | Updated:
Adam J. Gadzinski, MD, MS, on the Design of a Study Assessing Impact of Telemedicine on Patient-Reported OutcomesPublished: December 7th 2020 | Updated:
Adam J. Gadzinksi, MD, MS, on the Impact of Telemedicine on Patient-Reported OutcomesPublished: December 9th 2020 | Updated:
Adam J. Gadzinski, MD, MS, on the Research Coming Out of SUO This YearPublished: December 5th 2020 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
4
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
5
